- Lobbying
- PAUL AND D AND RYAN
Lobbying Arrangements Results for 'Paul D Ryan'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally, and/ Celgene specifically |
Celgene Corporation
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Merck specifically |
Merck & Co., Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biotechnology industry |
Sanofi US Services, Inc.
|
BGR Government Affairs | |||
Details Issues related to export controls. |
Teradyne, Inc.
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Issues related to child safety. |
Sandy Hook Promise Action Fund (fka Sandy Hook Promise Foundation)
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Issues related to U.S. export control policy. |
Coalition of Semiconductor Equipment Manufacturers
|
Akin, Gump, Strauss, Hauer & Feld | |||
Details Provide counsel and strategic guidance on legislation or regulations that may impact dental service organizations including the OSHA vaccine mandates and healthcare ETS, Medicaid, and the No Surpri... |
Association of Dental Support Organizations
|
BGR Government Affairs | |||
Details Issues related to China policy. |
The US-China Business Council
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Advocacy related to tariffs.; H.R. 3739 - FAIR TARIFF Act of 2023. |
Bell-Carter Foods
|
Akin, Gump, Strauss, Hauer & Feld | |||
Details Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics; implementation of health care reform; PDUFA; FDA reform; Trade issues |
Eli Lilly & Co, Inc.
|
BGR Government Affairs | |||
Details Procurement of information technology products and services, and address issues related to safety of computer products. Supporting commercial product acquisition of U.S. Government information tech... |
Hewlett-Packard Co.
|
MCDERMOTT WILL & EMERY LLP | |||
Details Issues relating to energy and transportation. |
Fluor Corporation
|
STEPTOE & JOHNSON LLP | |||
Details Provide strategic counsel and advocate on issues related to the biopharmaceutical industry generally, and Alkermes, Inc. specifically |
Alkermes, Inc.
Biopharmaceutical company |
BGR Government Affairs | |||
Details Provide guidance and advocacy with regard to regulations and legislation that could impact the pharmaceutical industry generally, and Zogenix specifically. |
Zogenix, Inc.
|
BGR Government Affairs | |||
Details Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulat... |
Kidney Care Partners
|
BGR Government Affairs | |||
Details Legislation and regulations affecting the long-term care pharmacy industry |
Senior Care Pharmacy Coalition
|
BGR Government Affairs | |||
Details Issues related to US export control policy. |
Cadence Design Systems, Inc.
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Medicare prospective payment system; Long Term Acute Care Hospitals (LTCH); implementation of health care reform; Physician fee schedule and IMPACT Act; Dr. Joanne Smith Memorial Rehabilitation Inn... |
Select Medical Corporation
|
BGR Government Affairs | |||
Details FY 23 appropriations legislation and policies pertaining to psoriatic disease public health activities. |
National Psoriasis Foundation
|
Faegre Drinker Biddle & Reath LLP | |||
Details Matters related to credit scores. |
Fair Isaac Corporation (FICO)
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Issues related to global investments. |
Chubb INA Holdings Inc.
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Issues related to financial services policy. |
BlackRock Funds Services Group LLC
|
Akin, Gump, Strauss, Hauer & Feld | |||
Details Strategic guidance and advocacy on health care related issues to include: healthcare reform, HIV/AIDS, bio-defense, Medicare/Medicaid and FDA |
GlaxoSmithKline, INC
|
BGR Government Affairs | |||
Details Provide advice and strategic counsel with regard to matters that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Ca... |
Amgen Inc.
|
BGR Government Affairs | |||
Details Issues related to importation of tobacco, vape products, and cigarettes; S.2131/ HR 4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024. |
Liggett Vector Brands LLC
|
Steptoe LLP | |||
Details Advise and advocate on clients behalf regarding ongoing public policy concerns impacting the innovative biopharmaceutical industry in Congress and throughout the Administration. |
Pharmaceutical Research and Manufacturers of America
|
BGR Government Affairs | |||
Details Advancing economic development goals through Coupangs expansion in current and new markets; Issues related to export promotion. |
Coupang, Inc.
|
Akin, Gump, Strauss, Hauer & Feld | |||
Details Issues related to the implementation of the Dodd-Frank Financial Reform Act. |
CIT Group, Inc.
|
MCDERMOTT WILL & EMERY LLP | |||
Details Issues related to the investment and commercialization of synthetic biology applications; House and Senate FY 2022 appropriations; USICA and America COMPETES. |
Synthetic Biology Coalition
|
Akin, Gump, Strauss, Hauer & Feld | |||
Details Issues related to promoting a trade agenda on health-related issues, including S. 2115/H.R. 4307 - Medical Supply Chain Resiliency Act. |
Trade Alliance for Health
|
Akin, Gump, Strauss, Hauer & Feld | |||
Details Medicare reimbursement; End stage renal disease (ESRD) payment reforms; extension of Medicare sequester; telehealth policy and waivers; issues pertaining to Medicare Secondary Payer Act |
Fresenius Medical Care
|
BGR Government Affairs | |||
Details Long-term care reform; Medicare and Medicaid payment policy; Medicare Advantage policy; arbitration issues; implementation of health care reform; bad debt relief; SGR replacement; NOTICE Act; Nurse... |
American Health Care Association
|
BGR Government Affairs | |||
Details HR 40 ARTICLE RETRIEVED FROM : https://www.congress.gov/bill/117th-congress/house-bill/40/all-info All Information (Except Text) for H.R.40 - Commission to Study and Develop Reparation Prop... |
Fighting Apartheid Confrontation Transformation Systems, Inc.
|
in-house lobbying | |||
Details Issues related to cryptocurrency and financial services, including H.R. 4763 - Financial Innovation and Technology for the 21st Century Act and H.R. 4766 - Clarity for Payment Stablecoins Act of 2023. |
LMAX Group
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Provide guidance and counsel with regard to federal medical device policy and regulatory issues and reimbursement issues within Medicare program, including IPPS Regulation, and FDA regulatory policy. |
Abiomed Inc.
|
BGR Government Affairs | |||
Details Issues related to public health preparedness; Issues related to access to drugs for minority communities; Issues related to healthcare education and screening. Issues regarding waiver of intellectu... |
Genentech Inc
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details General issues related to workforce recruitment and retention. |
Adobe, Inc.
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details H.R. 1631/S. 835 - Pro Codes Act. |
National Fire Protection Association
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Issues related to cryptocurrency and financial services, including H.R. 4763 - Financial Innovation and Technology for the 21st Century Act and H.R.4766 - Clarity for Payment Stablecoins Act. Issue... |
Crypto Council for Innovation
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Legislation regarding student athletes and college athletics; S.2495 - Protecting Athletes, Schools, and Sports Act of 2023. |
Southeastern Conference
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Section 337 public interest issues; issues related to water filtration and PFAS. |
Zero Technologies LLC d/b/a ZeroWater
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Legislation and regulation related to artificial intelligence. |
OpenAI OpCo, LLC
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Issues regarding future of work and workforce training and development, including H.R. 1084/S. 2878 - the Flexibility for Workers Education Act. |
1Huddle Inc
|
Akin, Gump, Strauss, Hauer & Feld | |||
Details Issues related to predatory and deceptive practices in the ticketing market. |
Fix The Tix Coalition
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Issues related to Pillar 2; Issues related to international tax reform. |
Amgen USA, Inc.
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details General transportation and infrastructure issues impacting the motorcoach industry; S. 1034/H.R. 2367 - Truck Parking Safety Improvement Act. Issues related to H.R. 2450 - Strengthening Supply Chai... |
American Bus Association, Inc.
|
Akin, Gump, Strauss, Hauer & Feld | |||
Details Issues related to the economic impact of various legislation on independent music venues; issues related to ticketing for live events. Issues related to predatory and deceptive ticketing practices.... |
National Independent Venue Association
|
Akin, Gump, Strauss, Hauer & Feld | |||
Details Communication with Department of State regarding Green Shipping Challenge; Department of Energy regarding Better Climate Challenge; and the EPA regarding Clean Ports Initiative. |
CMA CGM (America) LLC/Advocacy
|
Squire Patton Boggs | |||
Details - R&D tax credit - Issues related to the Tax Cuts & Jobs Act (PL 115-97), including the deduction for Foreign-Derived Intangible Income (FDII) and the minimum tax on Global Intangible Low-Taxed Inc... |
Thermo Fisher Scientific Inc.
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Appropriate treatment of timeshare consumer lending, including specifically with regard to Truth in Lending Act provisions, loan originator & other licensing, registration requirements, in any mort... |
Wyndham Worldwide Corporation
|
MCDERMOTT WILL & EMERY LLP |